BSE Live
Feb 26, 09:35Prev. Close
8820.65
Open Price
8899.85
Bid Price (Qty.)
8850.00 (1)
Offer Price (Qty.)
8873.50 (1)
NSE Live
Feb 26, 09:35Prev. Close
8869.00
Open Price
8826.50
Bid Price (Qty.)
8855.00 (1)
Offer Price (Qty.)
8868.50 (1)
| Cash Flow of AstraZeneca Pharma (in Rs. Cr.) | Mar 25 | Mar 24 | Mar 23 | Mar 22 | Mar 21 | |
| 12 mths | 12 mths | 12 mths | 12 mths | 12 mths | ||
| Net Profit/Loss Before Extraordinary Items And Tax | 156.36 | 219.54 | 134.10 | 83.04 | 127.09 | |
| Net CashFlow From Operating Activities | 65.36 | 27.87 | 58.29 | 100.80 | 104.78 | |
| Net Cash Used In Investing Activities | 30.80 | 21.74 | 18.11 | 4.74 | 173.03 | |
| Net Cash Used From Financing Activities | -65.59 | -44.38 | -24.48 | -9.46 | -8.97 | |
| Foreign Exchange Gains / Losses | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Adjustments On Amalgamation Merger Demerger Others | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Net Inc/Dec In Cash And Cash Equivalents | 30.57 | 5.23 | 51.92 | 96.08 | 268.84 | |
| Cash And Cash Equivalents Begin of Year | 505.57 | 500.34 | 448.42 | 352.34 | 83.50 | |
| Cash And Cash Equivalents End Of Year | 536.14 | 505.57 | 500.34 | 448.42 | 352.34 |
12.02.2026
01.02.2026
12.11.2025
AstraZeneca Standalone September 2025 Net Sales at Rs 559.09 crore, up 37.03% Y-o-Y
10.11.2025
12.11.2025
AstraZeneca Standalone September 2025 Net Sales at Rs 559.09 crore, up 37.03% Y-o-Y
06.06.2025
AstraZeneca Standalone March 2025 Net Sales at Rs 480.48 crore, up 25.39% Y-o-Y
17.02.2025
AstraZeneca Standalone December 2024 Net Sales at Rs 440.29 crore, up 43.98% Y-o-Y
21.11.2024
AstraZeneca Standalone September 2024 Net Sales at Rs 408.00 crore, up 31.16% Y-o-Y